Dr Murtaza Tambuwala is a Pharmaceutical and Molecular scientist, with an undergraduate degree in Pharmacy and has completed a Masters’ in Pharmaceutical Technology from the School of Pharmacy, Trinity College Dublin. Dr Tambuwala completed his doctoral research focused on elucidating the Hypoxia Inducible Factor (HIF) pathway in intestinal inflammation and the development of colon targeted drug-delivery system to deliver prolyl hydroxylases inhibitors to modulate (HIF) pathway as therapeutic strategy for Inflammatory bowel diseases, at the School of Medicine and Medical Sciences, University College Dublin (2011) under the tutelage of Prof. Cormac Taylor and Dr. Ivan Coulter (CEO of Sublimity Therapeutics); funded by Enterprise Partnership Doctoral Research Award from Irish Research Council.
He has also undertaken postdoctoral research training at Trinity Translational Medicine Institute, Trinity College Dublin under the tutelage of Prof. Padraic Fallon funded by a post-doctoral research award obtained from the Irish Research Council.

Dr Tambuwala joined Ulster University as a Lecturer in 2013 to establish his independent research in the field of Advanced Drug-delivery to modulate molecular targets using novel natural compunds, novel biologicals, peptides, and/or repurposed therapeutic agents to combat inflammation, cancer and infection. Dr Tambuwala has published > 170 peer-reviewed manuscripts and has co-authored 28 book chapters in books related to drug delivery and molecular medicine.

The over-arching aims of his research lab is to elucidate disease pathways, develop novel drug-delivery system to deliver novel and/or repurposed therapeutic agents to manipulate endogenous pathways for therapeutic outcomes in chronic inflammatory disease and cancers. Dr Tambuwala also works in collaboration with Nanotechnology and Integrated Bioengineering Centre (NIBEC) at Ulster University in the area of application of Plasma medicine for cancer and has developed several external collaboration world-wide with research working in the area of biosciences, drug-delivery, computational biology, infection, chemistry and engineering research.

Dr Tambuwala initiated and directs the MSc in Pharmaceutical Sciences via Distant learning (Online) and on-campus at Ulster University and is an active contributor in the delivery and development of the MPharm program at the School of Pharmacy and Pharmaceutical Sciences.

Dr Tambuwala also serves as a reviewer for UK research councils, UK research charities and several esteemed journals in the field of inflammation, infection, cancer and drug delivery research.